Insights

Strategic Focus Transdermal drug delivery platform with microporation offers a repositioning path for existing therapeutics and potential for new NCEs, signaling opportunities to partner with pharma companies seeking alternative administration routes.

Collaborative Potential Recent collaboration with Arcturus Therapeutics to explore transdermal mRNA delivery indicates openness to joint RD efforts and co-development deals with specialized biotech players.

Limited Scale, Niche Focus Small team size (2-10 employees) and revenue under one million suggest a boutique, highly specialized partner ideal for targeted BD outreach and smaller, milestone-driven collaborations.

Technology Leverage Proprietary PassPort system enabling needle-free, patch-based delivery across small molecules, peptides, oligonucleotides, and proteins positions the company to engage customers seeking innovative administration methods.

Market Entry Readiness Spin-out origin from a major materials company and established San Diego presence imply credible R&D backing and manufacturing readiness, which can be leveraged to approach mid-to-late-stage pharma and contract development partners.

Similar companies to PassPort Technologies, Inc.

PassPort Technologies, Inc. Tech Stack

PassPort Technologies, Inc. uses 8 technology products and services including iCIMS, Amazon Web Services, Open Graph, and more. Explore PassPort Technologies, Inc.'s tech stack below.

PassPort Technologies, Inc.'s Email Address Formats

PassPort Technologies, Inc. uses at least 1 email format:
PassPort Technologies, Inc. Email FormatsExamplePercentage
First.Last@passport-tech.comJohn.Doe@passport-tech.com
100%

Frequently Asked Questions

What is PassPort Technologies, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
PassPort Technologies, Inc.'s official website is passport-tech.com and has social profiles on LinkedIn.

How much revenue does PassPort Technologies, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, PassPort Technologies, Inc.'s annual revenue is estimated to be <$1M.

What is PassPort Technologies, Inc.'s NAICS code?

Minus sign iconPlus sign icon
PassPort Technologies, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does PassPort Technologies, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, PassPort Technologies, Inc. has approximately 3 employees across 1 continents, including North America. Key team members include Head Of Engineering: U. K. and Assistant Engineer I: A. C. Explore PassPort Technologies, Inc.'s employee directory with LeadIQ.

What industry does PassPort Technologies, Inc. belong to?

Minus sign iconPlus sign icon
PassPort Technologies, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does PassPort Technologies, Inc. use?

Minus sign iconPlus sign icon
PassPort Technologies, Inc.'s tech stack includes iCIMS, Amazon Web Services, Open Graph, Google Fonts API, RequireJS, PWA, Office 365 and Piwik PRO Core.

What is PassPort Technologies, Inc.'s email format?

Minus sign iconPlus sign icon
PassPort Technologies, Inc.'s email format typically follows the pattern of First.Last@passport-tech.com. Find more PassPort Technologies, Inc. email formats with LeadIQ.

When was PassPort Technologies, Inc. founded?

Minus sign iconPlus sign icon
PassPort Technologies, Inc. was founded in 2019.
PassPort Technologies, Inc. logo

PassPort Technologies, Inc.

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

PassPort Technologies, Inc. is a San Diego, California-based pharmaceutical manufacturing company focused on a transdermal drug delivery platform. The PassPort System combines microporation to create microscopic skin pores with a patch formulation that regulates drug absorption, enabling needle-free administration for drugs traditionally delivered by injection or infusion. The platform extends beyond small-molecule drugs to larger modalities such as peptides, oligonucleotides, and proteins, offering new administration options for a range of therapeutics.

Originating as a technology spin-out from Nitto Denko Corporation, the company was established in San Diego to pursue commercialization of this approach. It serves pharmaceutical developers seeking alternative routes for approved therapies or for new chemical entities that could benefit from transdermal delivery, positioning itself within the pharmaceutical manufacturing ecosystem as a specialized platform provider. In 2020, PassPort Technologies partnered with Arcturus Therapeutics to explore transdermal mRNA delivery, reflecting its engagement in collaborative research to expand potential applications.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2019
Employees
2-10

Section iconFunding & Financials

  • <$1M

    PassPort Technologies, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.